Bionovate Technologies Corp
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIIO research report →
About the company
Bionovate Technologies Corp. is a medical device enterprise dedicated to pioneering automated solutions for the treatment of age spots. Its core objective is to engineer a sophisticated, computer-driven system designed to precisely target and treat these blemishes on any area of the body.
- CEO
- Timothy Jones
- IPO
- 2014
- HQ
- Cham, CH
Price Chart
- Market Cap
- $775
- P/E
- -0.01
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -5.25
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 23.68%
- ROIC
- 17.07%
- Revenue
- $0 · 0.00%
- Net Income
- $-106,544 · 12.70%
- EPS
- $-0.00 · 51.02%
- Op Income
- $-45,371
- FCF YoY
- -331.37%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -3.48
- Avg Volume
- 63
Get TickerSpark's AI analysis on BIIO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BIIO coverage
Recent articles, reports, and earnings notes.
No research on BIIO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIIO report →Similar companies
Peers in the same neighborhood.